2026-05-08T21:08:15Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/203672024-09-27T08:13:12Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19605

00925njm 22002777a 4500 dc La Rosa, Giulio author Morillo, Carlos A author Quintanilla, Jorge G author Doltra, Adelina author Mont, Lluis author Rodríguez-Mañero, Moisés author Sarkozy, Andrea author Merino, José Luis author Vivas, David author Datino, Tomás author Calvo, David author Pérez-Castellano, Nicasio author Pérez-Villacastín, Julián author Fauchier, Laurent author Lip, Gregory author Hatem, Stéphane N author Jalife, José author Sanchis, Laura author Marín, Francisco author Filgueiras-Rama, David author 2024-02-29 Atrial fibrillation (AF) causes progressive structural and electrical changes in the atria that can be summarized within the general concept of atrial remodeling. In parallel, other clinical characteristics and comorbidities may also affect atrial tissue properties and make the atria susceptible to AF initiation and its long-term persistence. Overall, pathological atrial changes lead to atrial cardiomyopathy with important implications for rhythm control. Although there is general agreement on the role of the atrial substrate for successful rhythm control in AF, the current classification oversimplifies clinical management. The classification uses temporal criteria and does not establish a well-defined strategy to characterize the individual-specific degree of atrial cardiomyopathy. Better characterization of atrial cardiomyopathy may improve the decision-making process on the most appropriate therapeutic option. We review current scientific evidence and propose a practical characterization of the atrial substrate based on 3 evaluation steps starting with a clinical evaluation (step 1), then assess outpatient complementary data (step 2), and finally include information from advanced diagnostic tools (step 3). The information from each of the steps or a combination thereof can be used to classify AF patients in 4 stages of atrial cardiomyopathy, which we also use to estimate the success on effective rhythm control. Rev Esp Cardiol. 2024 Feb 29:S1885-5857(24)00072-0. 10.1016/j.rec.2024.02.009 1885-5857 Revista espanola de cardiologia (English ed.) 38428580 http://hdl.handle.net/20.500.12105/20367 Practical approach for atrial cardiomyopathy characterization in patients with atrial fibrillation.